![Antonio Benedetti](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Antonio Benedetti
Direktor/Vorstandsmitglied bei Cycle Pharmaceuticals Ltd.
Aktive Positionen von Antonio Benedetti
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cycle Pharmaceuticals Ltd.
![]() Cycle Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Cycle Pharmaceuticals Ltd. is a privately-owned biotechnology company headquartered in Cambridge, UK. The British company focuses on rare metabolic, immunological, and neurological genetic conditions, including multiple sclerosis. Cycle Pharmaceuticals utilizes the latest pharmaceutical technologies to provide superior drug treatments and individualized patient support services. Cycle Pharmaceuticals Ltd. was founded in 2012 with the aim of delivering drug treatments and services to the under-served rare disease patient community. James Alexander Harrison has been the CEO of the company since 2012. | Direktor/Vorstandsmitglied | 25.01.2016 | - |
Karriereverlauf von Antonio Benedetti
Statistik
International
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Cycle Pharmaceuticals Ltd.
![]() Cycle Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Cycle Pharmaceuticals Ltd. is a privately-owned biotechnology company headquartered in Cambridge, UK. The British company focuses on rare metabolic, immunological, and neurological genetic conditions, including multiple sclerosis. Cycle Pharmaceuticals utilizes the latest pharmaceutical technologies to provide superior drug treatments and individualized patient support services. Cycle Pharmaceuticals Ltd. was founded in 2012 with the aim of delivering drug treatments and services to the under-served rare disease patient community. James Alexander Harrison has been the CEO of the company since 2012. | Health Technology |
- Börse
- Insiders
- Antonio Benedetti
- Erfahrung